These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5481776)

  • 41. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 42. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF; Chase TN
    Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860
    [No Abstract]   [Full Text] [Related]  

  • 43. Phentolamine inhibition of human growth hormone secretion induced by L-DOPA.
    Cammani F; Massara F
    Horm Metab Res; 1972 Mar; 4(2):128. PubMed ID: 4554974
    [No Abstract]   [Full Text] [Related]  

  • 44. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I
    J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of L-dopa on anterior pituitary hormone release in man.
    Saito S; Abe K; Nagata N; Nakamura E; Tanaka K
    Endocrinol Jpn; 1972 Oct; 19(5):435-42. PubMed ID: 4678853
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of 1-dihydroxyphenylalanine (l-dopa), anesthesia and surgical stress on the secretion of growth hormone in the dog.
    Lovinger RD; Connors MH; Kaplan SL; Ganong WF; Grumbach MM
    Endocrinology; 1974 Nov; 95(5):1317-21. PubMed ID: 4426291
    [No Abstract]   [Full Text] [Related]  

  • 47. [Parkinson's disese. Treatment with L-dopa].
    Herskovits E; Matera R
    Prensa Med Argent; 1969 Oct; 56(35):1674-80. PubMed ID: 5399419
    [No Abstract]   [Full Text] [Related]  

  • 48. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical effects of L-dopa in Parkinson's disease].
    Fasano VA
    Sist Nerv; 1970; 22(2):119-23. PubMed ID: 5504550
    [No Abstract]   [Full Text] [Related]  

  • 50. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 52. L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion.
    Lucke C; Höffken B; Morgner KD
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):241-9. PubMed ID: 4479561
    [No Abstract]   [Full Text] [Related]  

  • 53. [Behavior of plasmatic HGH after stimulation with L-Dopa in normal elderly subjects and in subjects with cerebrovascular disorders: preliminary study].
    Bellastella A; Cafaro MR; Colucci CF; D'Alessandro B; Gasbarro R
    Boll Soc Ital Biol Sper; 1973 May; 49(10):586-91. PubMed ID: 4788780
    [No Abstract]   [Full Text] [Related]  

  • 54. [Oral L-dopa in the modern therapy of parkinsonian syndromes: general considerations; analysis of the first 50 personal cases].
    Guidetti B; Giuffrè R
    Sist Nerv; 1970; 22(2):196-202. PubMed ID: 5504557
    [No Abstract]   [Full Text] [Related]  

  • 55. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
    Podolsky S; Leopold NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of acute administration of L-dopa on body temperature in man.
    Boyd AE; Mager M; Angoff G; Lebovitz HE
    J Appl Physiol; 1974 Nov; 37(5):675-8. PubMed ID: 4436192
    [No Abstract]   [Full Text] [Related]  

  • 57. L-dopa stimulation of glucagon secretion in man.
    Rayfield EJ; George DT; Eichner HL; Hsu TH
    N Engl J Med; 1975 Sep; 293(12):589-91. PubMed ID: 1152893
    [No Abstract]   [Full Text] [Related]  

  • 58. Corticosteroid and growth hormone secretion in patients treated with L-dopa.
    von Werder K; van Loon GR; Yatsu F; Forsham PH
    Klin Wochenschr; 1970 Dec; 48(24):1454-6. PubMed ID: 4324569
    [No Abstract]   [Full Text] [Related]  

  • 59. [Fluctuations of plasma concentration of growth hormone (GH) and cortisol in man during administration of L-DOPA. Fluctuations of plasma concentration of cortisol in dogs during administration of dopamine into the 3d ventricle].
    Yozai S; Takahara J; Hanabusa M; Ofuji T
    Horumon To Rinsho; 1972 Jun; 20(6):495-501. PubMed ID: 4673195
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.
    Pekkarinen A; Rinne UK; Salokangas R; Siirtola T; Sonninen V
    Acta Neurol Scand Suppl; 1972; 51():129-30. PubMed ID: 4514339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.